The Federal Medical Centre (FMC), Abuja, has issued a press statement addressing public concern over the death of Ms. Ifunanya Lucy Nwagene, following widespread claims that hospitals she visited did not provide antivenom.
In a statement dated February 1, 2026 and shared on its official account on X (formerly Twitter), the hospital confirmed that Nwagene died from neurotoxic complications after a snake bite on January 31, 2026.
“We wish to address the circulating discussion on social media concerning the unfortunate case of Ms. Ifunanya Lucy Nwagene, who tragically passed away due to neurotoxic complications following a snake bite on January 31, 2026.”
The hospital expressed condolences to the bereaved family, stating: “First and foremost, we express our deepest condolences to the Nwagene family during this incredibly difficult time. The loss of a loved one is never easy, and our thoughts are with them.”
ALSO READ: Grammys 2026: Full list of winners
FMC Abuja said its medical team responded promptly upon the patient’s arrival and administered appropriate emergency care. “We want to clarify that the management team at Federal Medical Centre, Abuja acted promptly and with the utmost care upon Ms. Nwagene’s arrival. Our medical staff provided immediate and appropriate treatment, including resuscitation efforts, intravenous fluids, intranasal oxygen, and the administration of polyvalent snake antivenom.”
According to the statement, her condition worsened despite efforts to stabilize her and transfer her to intensive care. “After a thorough but quick evaluation, it was clear that Ms. Nwagene suffered severe neurotoxic complications from the snake bite. Despite all efforts to stabilize her condition and transfer her to the Intensive Care Unit for further treatment, she experienced a sudden deterioration just before the transfer. Our team of professionals worked diligently to provide CPR and other life-saving measures; however, despite these efforts, we were unable to revive her.”
The hospital also rejected allegations that antivenom was unavailable. “We stand by the quality of care and dedication our team demonstrates daily. The claims of non-availability of anti-snake venom and inadequate response are unfounded and do not reflect the reality of the situation.”
The statement concluded with a call for the public to rely on verified information. “In light of these events, we encourage our community to engage with credible sources for information and updates rather than relying on social media speculation. We remain available for any further inquiries or clarifications.”
The statement was signed by Dr. Bioku Muftau, Head of Clinical Services, Federal Medical Centre, Abuja.
